Michael C. Soulen, MD

Director Interventional Oncology
Abramson cancer Center, University of Pennsylvania

Presentation(s):

• Global IR Research - How to get started

  Sunday, March 5, 2023
  8:42 AM – 9:17 AM

  Disclosure information not submitted.

• Accurate non-invasive real-time spectral CT thermometry with physical density quantifications for thermal ablation

  Monday, March 6, 2023
  4:12 PM – 4:21 PM

  Disclosure(s): Astra Zeneca: Advisory Committee or Review Panel Member (Terminated); Genentech: Advisory Committee or Review Panel Member (Terminated); Guerbet LLC: Consultant (Ongoing), Research Grant Recipient (Ongoing); Pfizer: Research Grant Recipient (Ongoing); Sirtex Medical: Research Grant Recipient (Ongoing)

• Radioembolization 2

  Monday, March 6, 2023
  3:00 PM – 4:30 PM

  Disclosure(s): Astra Zeneca: Advisory Committee or Review Panel Member (Terminated); Genentech: Advisory Committee or Review Panel Member (Terminated); Guerbet LLC: Consultant (Ongoing), Research Grant Recipient (Ongoing); Pfizer: Research Grant Recipient (Ongoing); Sirtex Medical: Research Grant Recipient (Ongoing)

• Evolution in Management of Neuroendocrine Liver Metastases

  Tuesday, March 7, 2023
  8:30 AM – 10:00 AM

  Disclosure(s): Astra Zeneca: Advisory Committee or Review Panel Member (Terminated); Genentech: Advisory Committee or Review Panel Member (Terminated); Guerbet LLC: Consultant (Ongoing), Research Grant Recipient (Ongoing); Pfizer: Research Grant Recipient (Ongoing); Sirtex Medical: Research Grant Recipient (Ongoing)

• New clinical trials for NET liver metastases

  Tuesday, March 7, 2023
  8:30 AM – 8:43 AM

  Disclosure(s): Astra Zeneca: Advisory Committee or Review Panel Member (Terminated); Genentech: Advisory Committee or Review Panel Member (Terminated); Guerbet LLC: Consultant (Ongoing), Research Grant Recipient (Ongoing); Pfizer: Research Grant Recipient (Ongoing); Sirtex Medical: Research Grant Recipient (Ongoing)

• IR Demystified

  Tuesday, March 7, 2023
  5:00 PM – 6:00 PM

  Disclosure(s): Astra Zeneca: Advisory Committee or Review Panel Member (Terminated); Genentech: Advisory Committee or Review Panel Member (Terminated); Guerbet LLC: Consultant (Ongoing), Research Grant Recipient (Ongoing); Pfizer: Research Grant Recipient (Ongoing); Sirtex Medical: Research Grant Recipient (Ongoing)

• New and evolving clinical trials: embolotherapy

  Wednesday, March 8, 2023
  3:00 PM – 3:14 PM

  Disclosure(s): Astra Zeneca: Advisory Committee or Review Panel Member (Terminated); Genentech: Advisory Committee or Review Panel Member (Terminated); Guerbet LLC: Consultant (Ongoing), Research Grant Recipient (Ongoing); Pfizer: Research Grant Recipient (Ongoing); Sirtex Medical: Research Grant Recipient (Ongoing)